See inside every stock. Pro
S&P 5007,720▼ 0.30%Nasdaq26,185▼ 1.38%Dow Jones52,343▼ 0.25%Nasdaq 10029,403▼ 1.38%VIX17.20▲ 1.71%US Dollar101.93▼ 0.26%Gold spot4,054▼ 0.21%WTI104.59▲ 2.54%
← I1DX34 page
XStocksXray
Market X-Ray report · 29 October 2026

IDEXX Laboratories, Inc. (I1DX34)

B3 Stock Exchange · Brazil · prices in BRL · close of 29 Oct 2026

Key indicators

Last closeBRL 620.12
52-week range509.99 – 813.60
Return, 1 month / 3 months+15.2% / +6.1%
Return, 1 year / 3 years−10.7% / +40.6%
TrendUptrend
RSI (14)76
Volatility (1 year)29.8%
Worst drawdown (1 year)-37.3%
Average daily value traded0.00M BRL
Dividend yield–

Market X-Ray price-based

45/ 100 · High confidence · ahead of 39% of stocks on this exchange
Trend42
Momentum53
Stability (higher is calmer)57
Liquidity17
Income–

Five-year price chart navy: price · brown: 200-day average

3084425757098422021-102023-012024-042025-072026-10

About the company

IDEXX Laboratories provides diagnostic tests, instruments and software used mainly by veterinary practices that care for pets. The company supplies in-clinic testing equipment and reference laboratory services, along with practice management software, and it also serves livestock and poultry producers and water testing customers. IDEXX Laboratories is based in the United States and sells to customers in many countries around the world.

IDEXX Laboratories, Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code I1DX34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

IDEXX Laboratories, Inc. (I1DX34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 620.12 on 29 October 2026.

Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 886 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 10.7% and over the last three months it rose 6.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
IDEXX Laboratories, Inc. (I1DX34)

The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange

Lens and metricValueScoreReading
Trend42 · WeakBelow its long-term averages and far from its highs.
Above 200-day average4.1%
From 52-week high-23.8%
Momentum53 · FairTypical recent returns for this exchange.
3-month return6.1%
6-month return12.7%
12-month return, skipping the last month-22.5%
Stability (higher is calmer)57 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)29.8%
Worst drawdown, 1 year (smaller is calmer)-37.3%
Liquidity17 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.00M BRL
Zero-volume days68.3%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+8.8%
1 month+15.2%
3 months+6.1%
6 months+12.7%
1 year−10.7%
3 years+40.6%
5 years−15.3%

Signals

50-day / 200-day average550.34 / 595.87
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)10.04

Technical summary

DailyBullish12 bullish · 0 neutral · 4 bearish
WeeklyStrongly bullish10 bullish · 1 neutral · 1 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 30 Oct 2026